Results 31 to 40 of about 335,332 (300)
Lipids in Health and Disease, 2018 Background Although there have been many reports in the genetics of familial hypercholesterolemia (FH) worldwide, studies in regard of Chinese population are lacking.
Di Sun +13 more
doaj +1 more source
Prevalence of Dyslipidemia and Its Influencing Factors among Elderly Community Residents [PDF]
Zhongguo quanke yixue, 2023 Background Dyslipidemia is the most important and causal independent risk factor for atherosclerotic cardiovascular disease (ASCVD) . The prevalence of dyslipidemia in elderly residents in Guangdong Province is high, and it is urgent to analyze the ...
HUANG Qixian, WEN Yanting, HUANG Jun, LI Weibin, XU Yongneng, LIN Xiayi, WANG Haoxiang, WENG Fan, YANG Lianping
doaj +1 more source
Metabolic syndrome and cardiovascular risk after liver transplantation: a single-center experience. [PDF]
, 2012 Excessive weight gain, hypertension, hyperlipidemia, and diabetes are frequently observed among orthotopic liver transplantation (OLT) patients. These alterations, which are probably multifactorial in origin, contribute to posttransplantation metabolic ...
BERLOCO, Pasquale Bartolomeo +7 more
core +1 more source
The Effects of Obesity and Physical Activity on Dyslipidemia in Persons With Type 2 Diabetes [PDF]
The Asian Journal of Kinesiology, 2022 OBJECTIVES This study was conducted to examine the effect of obesity, and physical activity on the prevalence of dyslipidemia in persons with type 2 diabetes mellitus (T2DM). METHODS A cross-sectional, correlational design was used.
Yun-A Shin +3 more
doaj +1 more source
PRAS40 suppresses atherogenesis through inhibition of mTORC1-dependent pro-inflammatory signaling in endothelial cells [PDF]
, 2019 Endothelial pro-inflammatory activation plays a pivotal role in atherosclerosis, and many pro-inflammatory and atherogenic signals converge upon mechanistic target of rapamycin (mTOR).
Althoff, Till F. +14 more
core +1 more source
Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans
Chronic Diseases and Translational Medicine, 2018 Background: Previous studies have clearly demonstrated that XueZhiKang (XZK), an extract of cholestin, can decrease low-density lipoprotein cholesterol (LDL-C) and cardiovascular events. However, the mechanism of the effects of XZK on atherosclerosis (AS)
Rui-Xia Xu +14 more
doaj +1 more source
Frontiers in Public Health, 2023 ObjectivesThis study aimed to investigate the association between body mass index (BMI) and dyslipidemia and to explore the interaction between BMI and family history of dyslipidemia towards dyslipidemia in patients with type 2 diabetes.MethodsThis cross-
Xiang-Yu Chen +5 more
doaj +1 more source
Long-term prognosis for individuals with hypertension undergoing coronary artery calcium scoring [PDF]
, 2015 To examine the performance of coronary artery calcification (CAC) for stratifying long-term risk of death in asymptomatic hypertensive ...
Callister, Tracy Q +14 more
core +1 more source
Kidney & Blood Pressure Research, 2023 Introduction: Immunoglobulin A nephropathy (IgAN) is one of the most common glomerulonephritic diseases in the world. Several lines of evidence have suggested that dyslipidemia is related to the disease progression and prognosis of IgAN.
Sidi Liu +5 more
doaj +1 more source
Exploring metabolic dysfunction in chronic kidney disease [PDF]
, 2012 Impaired kidney function and chronic kidney disease (CKD) leading to kidney failure and end-stage renal disease (ESRD) is a serious medical condition associated with increased morbidity, mortality, and in particular cardiovascular disease (CVD) risk ...
Slee, Adrian D.
core +2 more sources